TY - JOUR
T1 - Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer
AU - Bogowicz, Marta
AU - Jochems, Arthur
AU - Deist, Timo M.
AU - Tanadini-Lang, Stephanie
AU - Huang, Shao Hui
AU - Chan, Biu
AU - Waldron, John N.
AU - Bratman, Scott
AU - O'Sullivan, Brian
AU - Riesterer, Oliver
AU - Studer, Gabriela
AU - Unkelbach, Jan
AU - Barakat, Samir
AU - Brakenhoff, Ruud H.
AU - Nauta, Irene
AU - Gazzani, Silvia E.
AU - Calareso, Giuseppina
AU - Scheckenbach, Kathrin
AU - Hoebers, Frank
AU - Wesseling, Frederik W. R.
AU - Keek, Simon
AU - Sanduleanu, Sebastian
AU - Leijenaar, Ralph T. H.
AU - Vergeer, Marije R.
AU - Leemans, C. Rene
AU - Terhaard, Chris H. J.
AU - van den Brekel, Michiel W. M.
AU - Hamming-Vrieze, Olga
AU - van der Heijden, Martijn A.
AU - Elhalawani, Hesham M.
AU - Fuller, Clifton D.
AU - Guckenberger, Matthias
AU - Lambin, Philippe
N1 - Funding Information:
This project was supported by the Swiss National Science Foundation Sinergia grant (310030_173303) and Scientific Exchange grant (IZSEZ0_180524). The clinical study used as one of the cohorts was supported by a research grant from Merck (Schweiz) AG. This work was also supported by the Interreg grant EURADIOMICS and the Dutch technology Foundation STW (grant n° 10696 DuCAT and n° P14-19 Radiomics STRaTegy), which is the applied science division of NWO, the Technology Program of the Ministry of Economic Affairs and the Manchester Cancer Research UK major centre grant. The authors also acknowledge financial support from the EU 7th framework program (ARTFORCE - n° 257144, REQUITE - n° 601826), CTMM-TraIT, EUROSTARS (E-DECIDE, DEEPMAM), Kankeronderzoekfonds Limburg from the Health Foundation Limburg, Alpe d’HuZes-KWF (DESIGN), The Dutch Cancer Society, the European Program H2020-2015-17 (ImmunoSABR - n° 733008 and BD2Decide - PHC30-689715), the ERC advanced grant (ERC-ADG-2015, n° 694812 - Hypoximmuno), SME Phase 2 (EU proposal 673780 – RAIL). Dr. Elhalawani was supported in part by the philanthropic donations from the Family of Paul W. Beach to Dr. G. Brandon Gunn, MD. Drs. Elhalawani and Fuller receive funding and project-relevant salary support from NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007-10). This research is supported by the Andrew Sabin Family Foundation; Dr. Fuller is a Sabin Family Foundation Fellow. Dr. Fuller receive funding and project-relevant salary support from the National Institutes of Health (NIH), including: National Institute for Dental and Craniofacial Research Award (1R01DE025248-01/R56DE025248-01); National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program(1R01CA218148-01); National Science Foundation (NSF), Division of Mathematical Sciences; NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825-01); NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787). Dr. Fuller has received direct industry grant support and travel funding from Elekta AB. We thank Jessica van Rossum for language editing of this manuscript.
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/3/11
Y1 - 2020/3/11
N2 - A major challenge in radiomics is assembling data from multiple centers. Sharing data between hospitals is restricted by legal and ethical regulations. Distributed learning is a technique, enabling training models on multicenter data without data leaving the hospitals ("privacy-preserving" distributed learning). This study tested feasibility of distributed learning of radiomics data for prediction of two year overall survival and HPV status in head and neck cancer (HNC) patients. Pretreatment CT images were collected from 1174 HNC patients in 6 different cohorts. 981 radiomic features were extracted using Z-Rad software implementation. Hierarchical clustering was performed to preselect features. Classification was done using logistic regression. In the validation dataset, the receiver operating characteristics (ROC) were compared between the models trained in the centralized and distributed manner. No difference in ROC was observed with respect to feature selection. The logistic regression coefficients were identical between the methods (absolute difference 0.05). In conclusion, both feature selection and classification are feasible in a distributed manner using radiomics data, which opens new possibility for training more reliable radiomics models.
AB - A major challenge in radiomics is assembling data from multiple centers. Sharing data between hospitals is restricted by legal and ethical regulations. Distributed learning is a technique, enabling training models on multicenter data without data leaving the hospitals ("privacy-preserving" distributed learning). This study tested feasibility of distributed learning of radiomics data for prediction of two year overall survival and HPV status in head and neck cancer (HNC) patients. Pretreatment CT images were collected from 1174 HNC patients in 6 different cohorts. 981 radiomic features were extracted using Z-Rad software implementation. Hierarchical clustering was performed to preselect features. Classification was done using logistic regression. In the validation dataset, the receiver operating characteristics (ROC) were compared between the models trained in the centralized and distributed manner. No difference in ROC was observed with respect to feature selection. The logistic regression coefficients were identical between the methods (absolute difference 0.05). In conclusion, both feature selection and classification are feasible in a distributed manner using radiomics data, which opens new possibility for training more reliable radiomics models.
KW - CELL LUNG-CANCER
KW - HEALTH-CARE
KW - EARLY DEATH
KW - MODEL
KW - RADIOCHEMOTHERAPY
KW - VARIABILITY
KW - STABILITY
KW - HYPOXIA
KW - PET
KW - CT
U2 - 10.1038/s41598-020-61297-4
DO - 10.1038/s41598-020-61297-4
M3 - Article
C2 - 32161279
SN - 2045-2322
VL - 10
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 4542
ER -